Literature DB >> 9822067

Antithrombotic agents in coronary artery disease.

J A Cairns1, P Théroux, H D Lewis, M Ezekowitz, T W Meade, G C Sutton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9822067     DOI： 10.1378/chest.114.5_supplement.611s

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  10 in total

Review 1.  Prevention of cardioembolic stroke.

Authors:  William David Freeman; Maria I Aguilar
Journal:  Neurotherapeutics       Date:  2011-07       Impact factor: 7.620

2.  Determination of who may derive most benefit from aspirin in primary prevention: subgroup results from a randomised controlled trial.

Authors:  T W Meade; P J Brennan
Journal:  BMJ       Date:  2000-07-01

3.  Use of antithrombotic agents among U.S. stroke survivors, 2000-2006.

Authors:  Eric M Cheng; Stanley N Cohen; Martin L Lee; Stefanie D Vassar; Alex Y Chen
Journal:  Am J Prev Med       Date:  2010-01       Impact factor: 5.043

Review 4.  Low-molecular-weight heparin should replace unfractionated heparin in the management of acute coronary syndromes.

Authors:  P J Zed
Journal:  J Thromb Thrombolysis       Date:  1999-08       Impact factor: 2.300

Review 5.  Low molecular weight heparins and coronary artery disease.

Authors:  P J Zed
Journal:  Curr Cardiol Rep       Date:  2000-01       Impact factor: 2.931

Review 6.  Clopidogrel: a review of its use in the prevention of atherothrombosis.

Authors:  B Jarvis; K Simpson
Journal:  Drugs       Date:  2000-08       Impact factor: 9.546

Review 7.  Dalteparin: an update of its pharmacological properties and clinical efficacy in the prophylaxis and treatment of thromboembolic disease.

Authors:  C J Dunn; B Jarvis
Journal:  Drugs       Date:  2000-07       Impact factor: 9.546

Review 8.  Low-molecular weight heparins in coronary artery disease.

Authors:  D Hunt
Journal:  Curr Atheroscler Rep       Date:  2001-03       Impact factor: 5.113

9.  Left Ventricular Thrombus.

Authors:  Peter J. Stokman; Charn S. Nandra; Richard W. Asinger
Journal:  Curr Treat Options Cardiovasc Med       Date:  2001-12

10.  Arterial indications for the low molecular weight heparins.

Authors:  Walter Ageno; Menno V Huisman
Journal:  Curr Control Trials Cardiovasc Med       Date:  2001
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.